Celestica Inc. (CLS)

We reiterate our Outperform and $75 target on the shares of Celestica (CLS; $45.32) after hosting investor meetings on Tuesday (9/10) in New York for CFO Mandeep Chawla and Craig Oberg, VP of IR and…

We believe the 19% decline in the shares of Celestica (CLS; $51.07; O/P), which has occurred over just the past seven trading days, represents a major buying opportunity in the stock, especially given its 4%…

Celestica (CLS; $53.39; O/P) reported Q2 non-IFRS EPS of $0.91, which beat our $0.80 and the Street’s $0.81 on better-than-expected sales of $2,392mm (vs. our $2,250mm and the Street’s $2,249mm). Recall, CLS’ Q2 outlook called…

We reiterate our Outperform and raise our target from $65 to $75 on the shares of Celestica (CLS; $63.27) ahead of its Q2 results, scheduled for next Wednesday (7/24 after market). Admittedly, our basis for…

We reiterate our Outperform on the shares of Celestica (CLS; $56.77) and bump up our target from $60 to $65 after we had the opportunity for a “big picture” discussion with CEO Rob Mionis, who…

We initiate coverage with an Outperform and $60 target on the shares of Celestica (CLS; $48.00), an electronics manufacturing services (EMS) provider, which after completing a portfolio transformation in 2021 is now well focused on…